E65D (p.Glu65Asp) variant of MFN2 (Mitofusin-2)

E65D (p.Glu65Asp) in MFN2 (Mitofusin-2) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.37 / 1. The record also includes population frequency data, published literature, and structural context.

E65D (p.Glu65Asp) variant details